Chemical structureResearch use only

CAT. NO. DC8660Featured

BML-210(CAY10433)

Name: BML-210(CAY10433)
Brand: DC Chemicals
SKU: DC8660
Price: 450.0 USD

Pack Sizes & Prices

TotalUS$450

We match the best price and quality on market.

Product overview

Description & Application

BML-210 is a novel HDAC inhibitor, and its mechanism of action has not been characterized.

Parameter	Value
Chemical Name	N1-(2-Aminophenyl)-N8-phenyloctanediamide
CAS No.	537034-17-6
Synonyms	bml-210;CAY10433;N'-(2-aminophenyl)-N-phenyloctanediamide;BML210;N1-(2-aminophenyl)-N8-phenyl-octanediamide;N1-(2-aminophenyl)-N8-phenyloctanediamide;BML 210;N-(2-aminophenyl)-N'-phenyl-octanediamide;Octanediamide, N-(2-aminophenyl)-N'-phenyl-;N-(2-aminophenyl)-N'-phenyoctanediamide;Probes2_000493;HMS3649B08;BCP16850;BDBM50222414;s1073;SMP2_000157
Formula	C20H25N3O2
M.Wt	339.4314
SMILES	O=C(C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(N([H])C1C([H])=C([H])C([H])=C([H])C=1[H])=O)N([H])C1=C([H])C([H])=C([H])C([H])=C1N([H])[H]
Purity	>98%
Storage	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological Activity

BML-210 is a novel HDAC inhibitor, and its mechanism of action has not been characterized.

In Vitro

No in vitro data are provided in the current product source. Contact us for further information.

In Vivo

No in vivo data are provided in the current product source. Contact us for further information.

References & source

DC Chemicals original product information

Published experimental findings depend on the model and assay conditions. They do not guarantee equivalent performance in every application. For laboratory research use only.

Product documentation

View online datasheet Request COA / MSDS

Refer to the certificate supplied with your lot for batch-specific release results.

Handling guide

2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Solution calculator

Related research products

DCAPI1434

Romidepsin（FK-228）

Romidepsin is a potent HDAC1 and HDAC2 inhibitor with IC50s of 36 and 47 nM, respectively.

View activity & prices

DC8036

CAY10603

CAY10603 is a potent and selective HDAC6 inhibitor, with an IC50 of 2 pM; CAY10603 also inhibits HDAC1, HDAC2, HDAC3, HDAC8, HDAC10, with IC50s of 271, 252, 0.42, 6851, 90.7 nM.

View activity & prices

DC3110

CUDC-907 (PI3K/HDAC InhibitorI)

Fimepinostat (CUDC-907) potently inhibits class I PI3Ks as well as classes I and II HDAC enzymes with an IC50 of 19/54/39 nM and 1.7/5.0/1.8/2.8 nM for PI3Kα/PI3Kβ/PI3Kδ and HDAC1/HDAC2/HDAC3/HDAC10 , respectively.

View activity & prices

DC7548

Nexturastat A

Nexturastat A is a potent and selective HDAC6 inhibitor with IC50 of 5 nM; no inhibition on other HDAC forms.Nexturastat A displayed low micromolar activity compared to the low nanomolar activity against HDAC6.…

View activity & prices

DC7183

Panobinostat(LBH589)

Panobinostat is a non-selective histone deacetylase (HDAC) inhibitor.

View activity & prices

DC7082

Belinostat (PXD101)

Belinostat inhibits the growth of tumor cells (A2780, HCT116, HT29, WIL, CALU-3, MCF7, PC3 and HS852) with IC50 from 0.2-0.66 μM. PD101 shows low activity in A2780/cp70 and 2780AD cells, which are cisplatin and…

View activity & prices

DC7978

Tucidinostat(Chidamide)

Chidamide is a synthetic benzamide-type HDAC inhibitor, inhibits HDAC1, HDAC2, HDAC3 and HDAC10 with IC50s of 95, 160, 67 and 78 nM, respectively.

View activity & prices

DC7037

R306465(JNJ-16241199)

R306465, also known as JNJ-16241199, is a novel hydroxamate-based histone deacetylase (HDAC) inhibitor with broad-spectrum antitumour activity against solid and haematological malignancies in preclinical models.

View activity & prices